Get a glimpse into our company and investor data—powered by the PitchBook Platform
Abbott Laboratories (rights to Gabitril)
Asset Purch.LATEST DEAL TYPE
A drug manufacturing rights. The drug is a treatment for partial seizures related to epilepsy enabling patience in reducing the frequency of partial seizures when added to an existing regimen of at least one other antiepilepsy drug.